Stable, recombinant ValiScreen® cell line expressing the Opioid delta receptor, human recombinant in CHO-K1 host cells.
false falsePlease enter valid quantity
Please log in to add favorites.
NULL OR EMPTY CART
Cell Line Terms and Conditions must be accepted before orders are placed. Additional agreement needed for commercial use.
爱游戏平台注册登录 ’s ValiScreen® cell lines are provided in two vials of frozen cells, each containing ∽2.5 x 106 cells. Detailed product information as well as recommended cell culture conditions and validation assay date are available for each cell line.
Clonal selection for 爱游戏平台注册登录 ’s ValiScreen cell lines is carried out with receptor binding. High and low expressors are then tested and selected for optimal binding and functional response according to the receptor specific transduction pathway.
爱游戏平台注册登录 ’s ValiScreen cell lines require accepted cell line Terms and Conditions prior to order processing. Additional agreement needed for commercial use. Contact us using the Request More Information button above for additional information regarding required documentation.
Assay Target Class | GPCR |
---|---|
Assay Validated | Binding |
Automation Compatible | Yes |
Host | CHO-K1 |
Product Brand Name | ValiScreen |
Receptor Type | Opioid |
Shipping Condition | Dry Ice |
Special Ordering Information | Requires accepted Terms and Conditions. Additional agreement needed for commercial use. |
Unit Size | 5 million cells |
Aequorin is a photo protein originating from the jellyfish Aequorea Victoria. The apo-enzyme (apoaequorin) is a 21 kD protein, which requires a hydrophobic prosthetic group, coelenterazine, to be converted to aequorin,the active form of the enzyme. This enzyme possesses 3 calcium binding sites which ...
爱游戏平台注册登录 ’s validated, ready-to-use AequoZen™or cAMPZen™ frozen, irradiated cells make it easier for you to perform functional testing of GPCRs. Just thaw and use! Reliable, convenient AequoZen cells for aequorin calcium testing or cAMPZen cells for cAMP testing let you get the testing done. So yo ...